A&A
April 15, 2020
Taking into account the references/representations received from various stakeholders seeking clarifications on eligibility of CSR expenditure related to COVID-19 activities, a set of FAQs along with clarifications has been provided by the Ministry of Corporate Affairs (“MCA”) for better understanding of the stakeholders vide its General Circular No. 15/2020 dated 10th April 2020.
The brief overview of the clarifications issued by MCA are as follows:
Navigate complexities of setting up a pharmaceutical manufacturing unit in India. Step-by-step guide covers regulatory, infrastructure, and success strategies.
View MoreEnsure legal compliance when registering a gaming company in India with this comprehensive checklist covering essential steps and regulations.
View MoreDiscover the impact of the Patent Cooperation Treaty (PCT) on emerging markets, examining both the opportunities it presents and the challenges it poses.
View MoreWe use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below. Read more...
We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below. Read more...
Comments
Post A Comment
Your email address will not be published *